The omega 3 market in the United States is expected to reach a projected revenue of US$ 1,460.9 million by 2033. A compound annual growth rate of 7.01% is expected of the United States omega 3 market from 2026 to 2033.
Orkla ASA, Basf SE, Omega Laboratories, Lonza Group Ltd, Croda International PLC, Austevoll Seafood ASA, Koninklijke DSM NV
Other key industry trends
In terms of revenue, U.S. accounted for 27.8% of the global omega 3 market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. omega 3 market is projected to lead the regional market in terms of revenue in 2033.
Canada is the fastest growing regional market in North America and is projected to reach USD 320.1 million by 2033.
The demand for omega 3 fatty acids in the U.S. is projected to grow significantly over the next few years owing to rising consumer awareness in the country regarding the health benefits offered by these acids. Moreover, growing consumer preference for a healthy diet that is rich in omega 3 nutrients is further projected to fuel the growth of omega 3 market in the U.S. over the forecast period.
Numerous omega 3 manufacturers present in the U.S., including BioProcess Algae, Martek Biosciences Corporation, and Omega Protein Corporation focus on research and development activities for launching pharmaceutical-grade omega 3 in the market.
This factor, along with increasing consumption of enhanced medicines to treat and prevent chronic diseases, is anticipated to spur the overall consumption of omega 3 in the U.S. in the coming years. Fish oil lowers blood pressure and triglyceride levels in consumers that help improve the conditions of hypertension and high cholesterol in adults.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Omega 3 Market Outlook will help companies and investors design strategic landscapes.
Docosahexaenoic Acid (Dha) was the largest segment with a revenue share of 59.08% in 2025.
Horizon Databook has segmented the U.S. omega 3 market based on docosahexaenoic acid (dha), eicosapentaenoic acid (epa), alpha-linolenic acid (ala), dpa, others type covering the revenue growth of each sub-segment from 2021 to 2033.
The demand for omega 3 fatty acids in the U.S. is projected to grow significantly over the next few years owing to rising consumer awareness in the country regarding the health benefits offered by these acids. Moreover, growing consumer preference for a healthy diet that is rich in omega 3 nutrients is further projected to fuel the growth of omega 3 market in the U.S. over the forecast period.
Numerous omega 3 manufacturers present in the U.S., including BioProcess Algae, Martek Biosciences Corporation, and Omega Protein Corporation focus on research and development activities for launching pharmaceutical-grade omega 3 in the market.
This factor, along with increasing consumption of enhanced medicines to treat and prevent chronic diseases, is anticipated to spur the overall consumption of omega 3 in the U.S. in the coming years. Fish oil lowers blood pressure and triglyceride levels in consumers that help improve the conditions of hypertension and high cholesterol in adults.
U.S. Omega 3 Market Type Outlook (Revenue, USD Million , 2021-2033)
Docosahexaenoic acid (DHA)
Eicosapentaenoic acid (EPA)
Alpha-linolenic acid (ALA)
DPA
Others Type
U.S. Omega 3 Market Application Outlook (Revenue, USD Million , 2021-2033)
Others Application
Pharmaceuticals
Infant Formula
Supplements & Functional Foods
Animal Feed & Pet Food
U.S. Omega 3 Market Source Outlook (Revenue, USD Million , 2021-2033)
Marine Source
Plant Source
Reasons to subscribe to Omega 3 Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Omega 3 Market Outlook databook
Our clientele includes a mix of Omega 3 Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Omega 3 Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Omega 3 Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.